ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      Current Value of Holding

      $803M

      Shares

      9.95M

      % of Portfolio

      2.32%

      Average Buy Price

      $93.9

      Avg closing price
      Price range

      22 Sands Capital Dexcom Trades

      Sands Capital's position in Dexcom is currently worth $803M. That's 2.32% of their equity portfolio (19th largest holding). The investor owns 2.72% of the outstanding Dexcom stock. The first Dexcom trade was made in Q1 2020. Since then Sands Capital bought shares ten more times and sold shares on eleven occasions. The investor's estimated purchase price is $934M, resulting in a loss of 14%.

      Avg closing price
      Price range
      Sold 4.5% shares (-466k shares) Q2 2025
      Avg closing price $78.37
      Price range $59.83 - $87.57
      Sold 6.3% shares (-695k shares) Q1 2025
      Avg closing price $81.74
      Price range $67.74 - $90.75
      Increased shares by 7.7% (+790k shares) Q4 2024
      Avg closing price $74.39
      Price range $65.68 - $81.01
      Sold 2.7% shares (-287k shares) Q3 2024
      Avg closing price $82.36
      Price range $64.00 - $116.06
      Sold 2.7% shares (-290k shares) Q2 2024
      Avg closing price $126.43
      Price range $110.31 - $140.45
      Sold 27.6% shares (-4.16M shares) Q1 2024
      Avg closing price $125.70
      Price range $114.22 - $140.10
      Increased shares by 10.2% (+1.4M shares) Q4 2023
      Avg closing price $102.16
      Price range $75.49 - $124.16
      Increased shares by 4.3% (+558k shares) Q3 2023
      Avg closing price $112.73
      Price range $86.06 - $137.93
      Sold 4.6% shares (-636k shares) Q2 2023
      Avg closing price $120.95
      Price range $112.47 - $130.98
      Sold 11.4% shares (-1.78M shares) Q1 2023
      Avg closing price $111.94
      Price range $104.00 - $122.92
      Sold 7.1% shares (-1.18M shares) Q4 2022
      Avg closing price $109.79
      Price range $84.98 - $122.67
      Sold 6.8% shares (-1.21M shares) Q3 2022
      Avg closing price $84.70
      Price range $76.35 - $94.18
      Increased shares by 6.8% (+1.15M shares) Q2 2022
      Avg closing price $91.26
      Price range $67.99 - $132.89
      Increased shares by 33.9% (+4.24M shares) Q1 2022
      Avg closing price $109.39
      Price range $94.08 - $130.20
      Sold 5.9% shares (-783k shares) Q4 2021
      Avg closing price $143.69
      Price range $129.87 - $162.82
      Increased shares by 9.5% (+1.15M shares) Q3 2021
      Avg closing price $126.11
      Price range $106.71 - $143.18
      Increased shares by 3.4% (+403k shares) Q2 2021
      Avg closing price $96.03
      Price range $80.99 - $107.93
      Sold 35.9% shares (-6.58M shares) Q1 2021
      Avg closing price $93.87
      Price range $84.79 - $104.74
      Increased shares by 96.5% (+9M shares) Q4 2020
      Avg closing price $89.29
      Price range $78.00 - $104.50
      Increased shares by 26.7% (+1.96M shares) Q3 2020
      Avg closing price $104.48
      Price range $95.51 - $112.95

      News about Dexcom Inc and Sands Capital

      Here¡¯s What Happened to Dexcom (DXCM) Stock in Q4

      Here¡¯s What Happened to Dexcom (DXCM) Stock in Q4

      Brown Capital Management, an investment management company, released its ¡°The Brown Capital Management Mid Company Fund¡± fourth quarter 2023 investor letter....

      Insider Monkey Insider Monkey, over 1 year ago
      Hedge Fund and Insider Trading News: Carlson Capital, SRS Investment Management, Oasis Management, Berkshire Hathway, DexCom, Inc. (DXCM), and More

      Hedge Fund and Insider Trading News: Carlson Capital, SRS Investment Management, Oasis Management, Berkshire Hathway, DexCom, Inc. (DXCM), and More

      Hedge Fund Carlson Shrinks To One Office After Assets Fall 90% (Bloomberg) Hong Kong Investor Files Court Injunction On NEC¡¯s JAE Stake Sale (The Business Ti...

      Insider Monkey Insider Monkey, over 1 year ago
      Capital World Investors Has $497.41 Million Position in DexCom, Inc. (NASDAQ:DXCM)

      Capital World Investors Has $497.41 Million Position in DexCom, Inc. (NASDAQ:DXCM)

      ¡­ the period. Capital World Investors ¡¯ holdings in DexCom were ¡­ funds and other institutional investors have also recently added ¡­ stock is owned by instit...

      EIN News Investing EIN News Investing, almost 2 years ago
      DexCom, Inc. (NASDAQ:DXCM) Holdings Trimmed by Brinker Capital Investments LLC

      DexCom, Inc. (NASDAQ:DXCM) Holdings Trimmed by Brinker Capital Investments LLC

      Brinker Capital Investments LLC trimmed its position in shares of DexCom, Inc. (NASDAQ:DXCM ¨C Get Rating) by 4.0% during the 4th quarter, HoldingsChannel rep...

      The AM Reporter The AM Reporter, over 2 years ago

      Embed chart

      Easily embed the chart on your blog or website ¨C it will always update automatically!

      HoMEÔçÒÒŮѸÀ×